Opioid Use, Unspecified Clinical Trial
Official title:
Evaluation of Opioids and Metabolites in Hair and Sweat of Pediatric Patients in a Monitored Clinical Context, by Means of Targeted Liquid Chromatography-tandem Mass Spectrometry
Hair analysis is a well-established and important tool in both forensic and clinical context. When it comes to the interpretation of positive hair analysis results, reliable and comprehensive reference data is essential. Such data on opioids, especially novel synthetic ones (such as fentanyl and its analogues (fentalogs)) is currently highly limited. This applies especially to hair with pediatric origin, due to differences in the metabolism and hair anatomy in children compared to adults. Investigators hypothesize that opioids, both traditional and novel synthetic ones exhibit detectable concentrations and distinct metabolite ratios within the hair matrices of pediatric patients. Thus, this observational, prospective research study provides 150 hair and sweat samples from children who received opioids as part of surgery or pain management. The samples will be consecutively extracted and analyzed using a sensitive targeted liquid chromatography-tandem mass spectrometry (LC-MS/MS) method, enabling the quantitative determination of the opioid and metabolite concentrations. The study thereby contributes valuable reference data for both forensic and clinical applications, addressing challenges in interpreting hair analysis results in especially pediatric populations. Further, a deeper understanding of the mechanisms (e.g. via sweat) and pharmacokinetic processes involved in the opioid incorporation to hair will be achieved. The study has received ethical approval from the Swiss Ethics Board (approval number: 2022-01693 / amendment approval date: 09.01.2024).
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06469177 -
Patient Centered Post-Op Pain Management Software Tool Interventional Study Verses Standard of Care
|
N/A | |
Terminated |
NCT02747875 -
Methadone vs. Fentanyl Administration on Postoperative Pain Control in Pediatric Patients Undergoing Cardiac Surgery
|
N/A | |
Completed |
NCT02244099 -
Controlled Substance Treatment Agreements in an Internal Medicine Residents' Clinic
|
N/A | |
Completed |
NCT02282306 -
Phone Interview to Prevent Recurring Opioid Overdoses
|
N/A | |
Recruiting |
NCT03923374 -
Opioid Use Disorder in Pregnancy in Long-Term Maternal/Infant Outcomes
|
||
Completed |
NCT04069403 -
An Opioid Prescribing Nudge
|
N/A | |
Completed |
NCT04155229 -
EMR Defaults to Nudge Opioid Prescribing
|
N/A | |
Completed |
NCT02299024 -
Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter
|
N/A | |
Recruiting |
NCT04564729 -
Shared Decision Aid for Post-Total Knee Arthroplasty Opioid Prescribing
|
N/A | |
Active, not recruiting |
NCT05283980 -
Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement
|
Phase 2/Phase 3 | |
Completed |
NCT04854551 -
Opioid Modulation and Neural Reward Activation in Healthy Adults
|
Phase 1/Phase 2 | |
Recruiting |
NCT06050551 -
Pigtail or Chest Tube Placement After Uniportal Video-assisted Thoracoscopic Surgery
|
N/A | |
Completed |
NCT04928339 -
Pecto-Intercostal Fascial Plane Block Study
|
Phase 4 | |
Completed |
NCT03773484 -
Application of Economics & Social Psychology to Improve Opioid Prescribing Safety (AESOPS): R21 Pilot Phase
|
N/A | |
Completed |
NCT02653144 -
the Analgesic Duration of Dexmedetomidine Compared to Dexamethasone as Adjuncts to Single Shot Interscalene Block
|
Phase 4 | |
Enrolling by invitation |
NCT05875857 -
Patient Utilization of Opioid Destruction Bags in the Post op Period
|
N/A | |
Recruiting |
NCT04275258 -
Collaborative Opioid Taper After Trauma: Preventing Opioid Misuse and Opioid Use Disorder
|
N/A | |
Completed |
NCT04252443 -
Nurses' Knowledge and Attitude About Opioids
|
N/A | |
Recruiting |
NCT05242081 -
Study on Opioid-free Anesthesia Protocol With S-ketamine and Propofol
|
N/A | |
Completed |
NCT02431793 -
EHR‐Based Medication Complete Communication Strategy to Promote Safe Opioid Use
|
N/A |